Is Neurogene Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Neurogene Inc (NGNE) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Neurogene Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neurogene Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Neurogene Inc?

Muslim investors may consider investing in Neurogene Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neurogene Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Neurogene Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neurogene Inc updated?

The Shariah compliance status of Neurogene Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neurogene Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neurogene Inc?

You can check the latest Shariah compliance status of Neurogene Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NGNE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 25, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Neurogene Inc (NGNE)

Based on 14 analysts giving stock ratings to Neurogene Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Neurogene Inc. Stock Analysis NGNE

United States Health Care Small Cap Report: 2025 Annual

The company is headquartered in New York City, New York and currently employs 131 full-time employees. The company went IPO on 2014-03-07.

Key Statistics of Neurogene Inc (NGNE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$29.63$31.04

Today's Open

$30.64

Volume

87.51K

P/E Ratio (TTM)

52 Week Range

$14.65$37.27

Market Cap

451.92M

Avg. Volume

178.68K

Dividend Yield

Financial Metrics & Statements of Neurogene Inc (NGNE)

FAQ's for Neurogene Inc (NGNE)

According to Musaffa’s Shariah screening methodology, Neurogene Inc (NGNE) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.